Scott M. Akamine's most recent trade in Kailera Therapeutics Inc. was a trade of 60,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kailera Therapeutics Inc | Scott M. Akamine | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Kailera Therapeutics Inc | Scott M. Akamine | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 60,000 | 60,000 | - | - | Stock Option (right to buy) |